NCT04480580

Brief Summary

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

July 20, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 21, 2020

Completed
Last Updated

July 21, 2020

Status Verified

July 1, 2020

Enrollment Period

1 month

First QC Date

July 20, 2020

Last Update Submit

July 20, 2020

Conditions

Covid19SurgerySARS (Severe Acute Respiratory Syndrome)

Keywords

SARS-CoV-2, surgery

Outcome Measures

Primary Outcomes (1)

  • Seroprevalence of SARS-CoV-2

    Positivity of specific IgM or IgG

    3 months

Study Arms (1)

Hospitalized patients

Diagnostic Test: SARS-CoV-2 Ab

Interventions

SARS-CoV-2 AbDIAGNOSTIC_TEST

Patient test for specific antibodies for SARS-CoV-2

Hospitalized patients

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in surgical department

You may qualify if:

  • Patients hospitalized during pandemic spread

You may not qualify if:

  • Incomplete data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Cagliari

Cagliari, CA, 09100, Italy

Location

MeSH Terms

Conditions

COVID-19Severe Acute Respiratory Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 21, 2020

Study Start

March 30, 2020

Primary Completion

April 30, 2020

Study Completion

June 30, 2020

Last Updated

July 21, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations

IT(1)